Diversity considerations in HIV-1 vaccine selection

Science

Volumn 296, Issue 5577, 2002, Pages 2354-2360

  Gaschen, Brian ^a   Taylor, Jesse ^a   Yusim, Karina ^a   Foley, Brian ^a   Gao, Feng ^a   Lang, Dorothy ^a   Novitsky, Vladimir ^a   Haynes, Barton ^a   Hahn, Beatrice H ^a   Bhattacharya, Tanmoy ^a   Korber, Bette ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; PROTEINS; VACCINES; VIRUSES;

DIVERSITY; IMMUNODEFICIENCY;

BIOMEDICAL ENGINEERING;

AMINO ACID; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG DEVELOPMENT; HUMAN IMMUNODEFICIENCY VIRUS; VACCINATION;

BIODIVERSITY; CROSS REACTION; DRUG DESIGN; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION PREVENTION; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS STRAIN;

AIDS VACCINES; BASE SEQUENCE; CONSENSUS SEQUENCE; CROSS REACTIONS; EVOLUTION, MOLECULAR; GENE PRODUCTS, ENV; GENOME, VIRAL; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; LIKELIHOOD FUNCTIONS; PHYLOGENY; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0037189323     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1070441     Document Type: Review

References (54)